All In Biotech

Drug Trial Radar · NCT03499704

A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy

A Multicenter, Randomized, Open-label, Two-arm, Phase 4 Study to Evaluate the Effect of Add-on Pioglitazone or Dapagliflozin in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled by Dipeptidyl Peptidase-4 Inhibitor and Metformin Therapy

Last checked: Nov 20, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 133 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

133

Actual

Start

Feb 11, 2020

Primary completion

Jan 2, 2024

Study completion Jan 16, 2024

Sponsor

Lead sponsor
Celltrion Pharm, Inc.Industry
Sponsor type
Industry
First posted
Apr 17, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c) change from baseline at Week 26.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • Pioglitazone + AlogliptinDrug

    Pioglitazone and Alogliptin FDC tablets

  • AlogliptinDrug

    Alogliptin tablets.

  • MetforminDrug

    Metformin tablets.

  • DapagliflozinDrug

    Dapagliflozin tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change from Baseline in HbA1c at Week 26Time frame: Baseline and Week 26

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Inje University Haeundae Paik Hospital

    Busan, South Korea

  • Pusan National University Hospital

    Busan, South Korea

  • YeungNam University Hospital

    Daegu, South Korea

  • Daejeon Eulji Medical Center, Eulji University

    Daejeon, South Korea

  • Chosun University Hospital

    Gwangju, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Kangbuk Samsung Hospital

    Seoul, South Korea

  • Yonsei University Health System Severance Hospital

    Seoul, South Korea

  • Kyung Hee University Hospital at Gangdong

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Ulsan University Hospital

    Ulsan, South Korea

  • The Catholic University of Korea, Bucheon, St. Marys Hospital

    Bucheon-si, Gyeonggi-do, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

  • The Catholic University of Korea, ST. Vincents Hospital

    Suwon, Gyeonggi-do, South Korea

  • Ajou University Hospital

    Suwon, Gyeonggi-do, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.